ENT4 as a Target of EWS/WT1 in Desmoplastic Small Round Cell Tumor
Author Information
Author(s): Li Hongjie, Smolen Gromoslaw A., Beers Lisa F., Xia Li, Gerald William, Wang Joanne, Haber Daniel A., Lee Sean Bong
Primary Institution: National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health
Hypothesis
Is ENT4 a direct target of the EWS/WT1 translocation product in desmoplastic small round cell tumor?
Conclusion
ENT4 is highly expressed in desmoplastic small round cell tumors and is activated by both isoforms of EWS/WT1, suggesting it may be a potential therapeutic target.
Supporting Evidence
- ENT4 is transcriptionally activated by both isoforms of EWS/WT1.
- ENT4 is highly expressed in primary tumors of desmoplastic small round cell tumors.
- Treatment with adenosine analogs increased cytotoxic response in DSRCT cells.
Takeaway
This study found that a gene called ENT4 is very active in a type of cancer called desmoplastic small round cell tumor, which could help doctors find new ways to treat it.
Methodology
The study used promoter-reporter assays, chromatin immunoprecipitation, and quantitative RT-PCR to analyze ENT4 expression and regulation.
Limitations
The study primarily focused on a limited number of tumor samples and cell lines.
Participant Demographics
The study involved tumor samples from patients with desmoplastic small round cell tumors.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website